RedHill Biopharma (RDHL) Accumulated Expenses (2016 - 2025)
RedHill Biopharma (RDHL) posted quarterly Accumulated Expenses of $12.0 million for Q4 2025, up 20.24% year-over-year from $10.0 million in Q4 2024, and up 12.45% quarter-over-quarter from $10.7 million in Q2 2025.
RedHill Biopharma (RDHL) Accumulated Expenses (2016 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Accumulated Expenses for 10 consecutive years, with $12.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Accumulated Expenses rose 20.24% year-over-year to $12.0 million; the TTM figure through Dec 2025 stood at $12.0 million (up 20.24% YoY), while the FY2025 annual figure was $12.0 million, up 20.24% from the prior year.
- Accumulated Expenses grew to $12.0 million in Q4 2025 per RDHL's latest filing, from $10.7 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $25.4 million in Q1 2021 and bottomed at $4.0 million in Q2 2024.
- Historically, Accumulated Expenses has averaged $16.0 million across 5 years, with a median of $17.9 million in 2022.
- Annual changes were most pronounced in 2023 — Accumulated Expenses slumped 74.42% — and 2025, when it jumped 169.78%.
- RedHill Biopharma's Accumulated Expenses stood at $20.9 million in 2021, then declined by 14.1% to $17.9 million in 2022, then plunged by 74.42% to $4.6 million in 2023, then jumped by 117.62% to $10.0 million in 2024, then gained by 20.24% to $12.0 million in 2025.
- Business Quant data shows RDHL's Accumulated Expenses at $12.0 million in Q4 2025, $10.7 million in Q2 2025, and $10.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.02 Mn |
| Jun 30, 2025 | 10.69 Mn |
| Dec 31, 2024 | 9.99 Mn |
| Jun 30, 2024 | 3.96 Mn |
| Dec 31, 2023 | 4.59 Mn |
| Jun 30, 2023 | 7.40 Mn |
| Mar 31, 2023 | 17.13 Mn |
| Dec 31, 2022 | 17.95 Mn |
| Sep 30, 2022 | 21.20 Mn |
| Jun 30, 2022 | 20.21 Mn |
| Mar 31, 2022 | 24.15 Mn |
| Dec 31, 2021 | 20.90 Mn |
| Sep 30, 2021 | 20.59 Mn |
| Jun 30, 2021 | 23.16 Mn |
| Mar 31, 2021 | 25.45 Mn |
| Dec 31, 2020 | 24.08 Mn |
| Sep 30, 2020 | 23.54 Mn |
| Jun 30, 2020 | 29.19 Mn |
| Mar 31, 2020 | 12.91 Mn |
| Dec 31, 2019 | 4.33 Mn |